Thermo Fisher Scientific Inc (TMO)
Debt-to-equity ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | 18,773,000 | 18,641,000 | 19,107,000 | 21,091,000 | 20,638,000 | 19,231,000 | 17,076,000 | 16,392,000 | — | — |
Total stockholders’ equity | US$ in thousands | 46,735,000 | 45,328,000 | 43,752,000 | 42,257,000 | 43,978,000 | 43,549,000 | 42,293,000 | 40,956,000 | 40,793,000 | 38,710,000 | 36,854,000 | 35,058,000 | 34,507,000 | 31,824,000 | 29,875,000 | 28,559,000 | 29,675,000 | 29,355,000 | 28,729,000 | 27,693,000 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 | 0.53 | 0.55 | 0.66 | 0.69 | 0.67 | 0.58 | 0.56 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $46,735,000K
= 0.00
The debt-to-equity ratio of Thermo Fisher Scientific Inc. has shown some fluctuations over the past eight quarters. In Q4 2023, the ratio was 0.75, indicating that the company had $0.75 in debt for every $1 of equity. This ratio decreased compared to the previous quarter (Q3 2023) when it was 0.78.
Looking back further, the trend has been somewhat variable. The ratio was relatively stable around the range of 0.72 to 0.78 from Q2 2022 to Q2 2023, with a spike to 0.83 in Q1 2023.
Analyzing the data, it appears that Thermo Fisher Scientific Inc. has been managing its debt levels in relation to equity, with the ratio staying within a certain range. The increase in Q1 2023 to 0.83 may indicate a temporary increase in debt or a decrease in equity during that period.
Overall, while the ratio has fluctuated, it seems that the company has maintained a reasonable balance between debt and equity in its capital structure. Investors and stakeholders may want to continue monitoring this ratio in future quarters to assess the company's financial leverage and risk profile.
Peer comparison
Dec 31, 2023
See also:
Thermo Fisher Scientific Inc Debt to Equity (Quarterly Data)